FNILX
Price
$23.36
Change
+$0.09 (+0.39%)
Updated
Aug 28 closing price
Net Assets
14.1B
VITSX
Price
$155.84
Change
+$0.56 (+0.36%)
Updated
Aug 28 closing price
Net Assets
1.91T
Interact to see
Advertisement

FNILX vs VITSX

Header iconFNILX vs VITSX Comparison
Open Charts FNILX vs VITSXBanner chart's image
Fidelity ZERO Large Cap Index
Price$23.36
Change+$0.09 (+0.39%)
VolumeN/A
Net Assets14.1B
Vanguard Total Stock Market Idx I
Price$155.84
Change+$0.56 (+0.36%)
VolumeN/A
Net Assets1.91T
FNILX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNILX vs. VITSX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNILX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.91T vs. FNILX (14.1B). VITSX pays higher dividends than FNILX: VITSX (1.19) vs FNILX (1.00). FNILX was incepted earlier than VITSX: FNILX (7 years) vs VITSX (28 years). VITSX (0.03) is less costly to investors than FNILX (0.00). FNILX is a more actively managed with annual turnover of: 3.00 vs. VITSX (2.00). FNILX has a lower initial minimum investment than VITSX: FNILX (0) vs VITSX (5000000). FNILX annual gain was more profitable for investors over the last year : 18.11 vs. VITSX (15.92). FNILX return over 5 years is better than : 97.09 vs. VITSX (80.23).
FNILXVITSXFNILX / VITSX
Total Expense Ratio0.000.03-
Annual Report Gross Expense Ratio0.000.03-
Fund Existence7 years28 years-
Gain YTD11.23310.140111%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets14.1B1.91T1%
Annual Yield % from dividends1.001.1984%
Returns for 1 year18.1115.92114%
Returns for 3 years69.9158.15120%
Returns for 5 years97.0980.23121%
Returns for 10 yearsN/A224.16-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUOL322.784.85
+1.53%
Duolingo
NBR36.330.14
+0.39%
Nabors Industries Ltd
ATOS0.75-0.01
-0.97%
Atossa Therapeutics
PMCB0.96-0.01
-1.03%
PharmaCyte Biotech
LU2.96-0.06
-1.99%
Lufax Holding Ltd